Patients who received Ross procedure demonstrate excellent survival rates after 20 years
Young patients who have undergone the Ross procedure for aortic valve disease have shown excellent long-term survival, the ...
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st ...
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced data from the AMDS PERSEVERE clinical trial (the "IDE") was presented in a ...
News Medical4 天
Ross procedure offers durable results in young patients
Young patients who have undergone the Ross procedure for aortic valve disease have shown excellent long-term survival, the ...